Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

Ambu Awarded Single-Use Endoscopy Contract with Major U.S. Group Purchasing Organization

Ambu Inc. has been awarded a national single-use endoscopy contract in the category of Single-Use Endoscopes with a major U.S. Group Purchasing Organization (GPO).
The agreement is for the single-use endoscopy category and enables Ambu to serve approximately 20% of the acute care hospitals in the United States. This agreement will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by giving those accounts pre-negotiated pricing and terms for Ambu’s full suite of endoscopy products.

This comprehensive category will provide access to the full Ambu portfolio of FDA-approved single-use endoscopes and allow members the choice to partner with Ambu by standardizing across Ambu’s single-use product portfolio – including Bronchoscopy, ENT, Urology, and Gastroenterology.

“We welcome the decision to create a single-use endoscopy category and are looking forward to an exciting journey together bringing advanced single-use devices to hospitals and health care providers. Ambu’s aspiration is to become the world’s most innovative single-use endoscopy company on the back of a comprehensive portfolio, unmatched innovation and attractive economics. This strategy makes us the ideal partner for GPOs in the United States and we are excited to have secured another major award,” said Juan Jose Gonzalez, CEO of Ambu A/S.



Submit a Comment

Your email address will not be published. Required fields are marked *